Executive Guidance: Protecting Clinical Integrity The transition of BPC-157 to Category 2 represents a clear enforcement priority regarding synthetic peptides
This gradual method helps reduce the risk for nausea and other stomach upset
BPC-157 is not recommended for anyone who is pregnant, may become pregnant, or nursing, nor is it endorsed to be used by children
This information is crucial for us to provide appropriate recommendations, such as adjusting drug administration before elective procedures, recommending extended fasting, or rescheduling an elective procedure if necessary. The authors noted that in June, 2023, the American Society of Anesthesiologists issued new suggestions to physicians for evaluating GLP-1 RA use before surgery, and for informing patients about related risks of adverse outcomes
GLP-1 related hair loss is usually temporary and resolves once weight stabilizes
After you achieve your goal weight, we will monitor and adjust your semaglutide dosage to maintain results with eventual discontinuation of the medication
